Navigation Links
Nanogea Announces New Scientific Advisory Board Members
Date:10/9/2009

Nanogea Adds Drs. C. Thomas Caskey and Saul Tendler to its Scientific Advisory Board

Westlake Village, Calif. (PRWEB) October 9, 2009 -- Nanogea, a nano-biotech company focused on commercializing the industry's most sensitive single molecular detection platform, is pleased to announce today that Dr. C. Thomas Caskey and Dr. Saul Tendler have joined its scientific advisory board.

Dr. Caskey is a prominent medical geneticist and biomedical entrepreneur. Dr. Caskey presently serves as Director and Chief Executive Officer of the Brown Foundation Institute of Molecular Medicine, a research institute that seeks to investigate the cause of human diseases at the cellular and molecular levels using DNA and protein technologies to expose disease mechanisms. He is a former founding Director and CEO of Cogene Biotech Ventures, venture capital funds designed to support early-stage biotechnology and life science companies. Dr. Caskey is a former SVP for Res. at Merck and Trustee and President of the Merck Genome Res. Inst. as well as an Ex-Chief of Section of Medical Genetics and Professor of Medicine and Biochemistry, Baylor College of Medicine. He sits on the boards of Essex Woodlands Health Ventures, Luminex, Odyssey Thera, En Vivo, Metabolon, Genome Canada, LabCorp. of America, and Vice Chair of Genome Canada. Dr. Caskey is a member of the Academy of Medicine, Engineering and Science of Texas (President of TAMEST 2004-05), a member of the National Academy of Sciences, and the Institute of Medicine. Dr. Caskey received his medical doctorate from Duke University. He is Board certified in Internal Medicine, Clinical Genetics, Metabolic Diseases, and Molecular Diagnostics.

Dr. Saul Tendler is Pro-Vice-Chancellor, Professor of Biophysical Chemistry and Head of the School of Pharmacy, University of Nottingham. His expertise is in the field of biophysical chemistry, with a particular focus on analy
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors
2. IridoTech Announces IridoLab Self Service Kiosk
3. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
4. NCIIA Announces New Undergraduate Competition
5. Sangamo Announces Pricing of Public Offering of Common Stock
6. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
7. Verenium Announces Proposed Public Offering of Common Stock
8. Boston Scientific Announces Exclusive Sponsorship and First Enrollments of MADIT-RIT Clinical Trial
9. YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD., AN AUSTRALIAN CANCER-FOCUSED DEVELOPMENT COMPANY
10. ThromboGenics Announces Results From a Phase IIa Trial Evaluating Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
11. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Capitalizing on the continued strong ... active venture capital market, leaders from BioCrossroads, Eli ... Indiana University, Purdue University, the University of Notre ... today announced the establishment of the INext Fund, ... ,, Organized through BioCrossroads, Indiana,s initiative to grow, ...
(Date:12/16/2009)... culture supplement? InVitria has what scientists have been asking for! ... improves the growth and productivity of CHO cells. Developed for ... animal free, well defined and consistent recombinant CHO supplement. ... ... 16, 2009 -- Scientists working with CHO cells can now ...
(Date:12/15/2009)... (JBEI), one of three Department of Energy (DOE) bio-energy ... to protect its valuable intellectual property. , ... ... 15, 2009 -- Surety, LLC , the leading ... announced that the Joint BioEnergy Institute (JBEI), one of ...
(Date:12/15/2009)... CHARLOTTESVILLE, Va., Dec. 15 AstraZeneca ... University of Virginia (UVa) in Charlottesville, today ... strategic research collaboration to enhance development of ... (CAD) with a secondary focus on peripheral ... ) ,, The collaborative preclinical research ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3
... March 2 Morphotek(R), Inc., a subsidiary of,Eisai ... has commenced a,multi-centered Phase II study of its ... MORAb-009, plus the chemotherapy drugs,pemetrexed and cisplatinum, as ... The primary objective of the ...
... March 2 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ... obtained a new Senior Secured Term Loan and Revolving ... arranger, administrative agent and lender for both the Term ... a delayed draw secured term loan facility of up ...
... California Institute for Regenerative Medicine ("CIRM") completed a two part ... manufacturing facility, R&D lab and corporate headquarters. , ... ... -- Leadership of the California Institute for Regenerative Medicine ("CIRM") ...
Other Biology Technology:Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 2Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 3Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities 4CIRM Completes Briefing Visit to Stemedica Cell Technologies 2CIRM Completes Briefing Visit to Stemedica Cell Technologies 3
(Date:12/16/2009)... -- DigitalPersona, Inc., a leader in fingerprint ... agreement with IBM to deploy a new ... on IBM SurePOS 500 retail systems. The ... to more easily and quickly identify users ... to the individuals who perform them. ...
(Date:12/16/2009)... Solutions Inc. is pleased to announce it has ... previously operating as IgeaCare Systems Inc. The newly ... new leadership and funding. ,, IgeaCare Solutions Inc. ... of Chief Executive Officer. Under his direction, the ... servicing and support model; fast and accurate delivery ...
(Date:12/16/2009)... Va., Dec. 9 CSC (NYSE: ... the American Association for Laboratory Accreditation awarded ... (ISO/IEC) 17025:2005 accreditation to the company,s Test ... Identity Labs located in Fairmont, W.Va. The ... laboratory in the world to achieve this ...
Breaking Biology News(10 mins):DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2CSC's Identity Management and Biometric Test Lab Achieves ISO/IEC 17025 Accreditation 2New research shows dinosaurs may have been smaller than we thought 9003 1New research shows dinosaurs may have been smaller than we thought 9003 2Environmental cues control reproductive timing and longevity University of Minnesota study shows 9001 1Environmental cues control reproductive timing and longevity University of Minnesota study shows 9001 2Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 1Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 2Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 3Broad Coalition Says Consumer Role Is Key to Improving Health and Health Care 50066 4
... morbidity and mortality worldwide. Several interacting environmental, biochemical, ... While some of the genes involved in the ... to be discovered. During the last few decades, ... linkage and association methods, and with more targeted ...
... new blood test that can give an early diagnosis ... disease could be launched this summer, reports Marina Murphy ... proteomics company, Power3 Medical Products, said it plans to ... diagnostic test for neurodegenerative diseases on the market, in ...
... rapid weight gain believed to afflict many new college students when ... urban legend: a cautionary tale often told but not well substantiated. ... - located in one of the states with the highest prevalence ... only 1.9 pounds during the first semester, with women gaining slightly ...
Other Biology News:Genetic variants of USF1 are associated with the increased risk for cardiovascular disease 2First diagnostic test for Alzheimer's and Parkinson's disease on the horizon 2Fabled 'Freshman 15' pound gain more often only 5, report researchers 2
FEN-1 (B-4)...
Synphilin 1 Immunogen: Synthetic peptide corresponding to residues S(829) L E L N G E K D K D K G R T L Q R T(847) of human Synphilin 1. Storage: -20 C, Avoid Freeze/Thaw Cycles...
KAI 1 (G-2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...
Biology Products: